Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 03, 2018 08:00 ET | Source: Entasis Therapeutics Holdings Inc.

Entasis Therapeutics to Present on ETX2514SUL at IDWeek 2018

WALTHAM, Mass., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Entasis Therapeutics (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial...
September 25, 2018 21:55 ET | Source: Entasis Therapeutics Holdings Inc.

Entasis Therapeutics Announces Pricing of Initial Public Offering

WALTHAM, Mass., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel...